Preparation of doxorubicin-containing chitosan microspheres for transcatheter arterial chemoembolization of hepatocellular carcinoma

References

• Al-Helw AA, Al-Angary AA, Mahrous GM, Al-Dardari MM. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone. Journal of Microencapsulation 1998; 15: 373–382
   PubMed Web of Science ®Google Scholar
• Berthold A, Cremer K, Kreuter J. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. Journal of Controlled Release 1996; 39: 17–25
   Web of Science ®Google Scholar
• Bogataj M, Mrhar A, Grabnar I, Rajtman Z, Bukovec P, Srcic S, Urleb U. The influence of magnesium stearate on the characteristics of mucoadhesive micro spheres. Journal of Microencapsulation 2000; 17: 499–508
   PubMed Web of Science ®Google Scholar
• Cameron M, Zhou GX, Hicks MB, Antonucci V, Ge Z, Lieberman DR, Lynch JE, Shi YJ. Employment of on-line FT-IR spectroscopy to monitor the deprotection of a 9-fluorenylmethyl protected carboxylic acid peptide conjugate of doxorubicin. Journal of Pharmaceutical and Biomedical Analysis 2000; 28: 137–144
   Google Scholar
• Carr BI. Hepatic arterial 90Yttrium glass microspheres (Thrasphere) for unrespectable hepatocellular carcinoma: Interim safety and survival data on 65 patients. Liver Transplantation 2004; 10: S107–110
   Google Scholar
• Chen JH, Lin YC, Huang YS, Chen TJ, Lin WY, Han KW. Induction of VX2 carcinoma in rabbit liver: Comparison of two inoculation methods. Lab Animals 2004; 38: 79–84
   PubMedGoogle Scholar
• Chiou SH, Wu WT, Huang YY, Chung TW. Effects of the characteristics of chitosan on controlling drug release of chitosan coated PLLA micro spheres. Journal of Microencapsulation 2001; 18: 613–625
   PubMed Web of Science ®Google Scholar
• Coppi G, Iannuccelli V, Leo E, Bernabei MT, Cameroni R. Protein immobilization in crosslinked alginate microparticles. Journal of Microencapsulation 2002; 19: 37–44
   PubMed Web of Science ®Google Scholar
• Dini E, Alexandridou S, Kiparissides C. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications. Journal of Microencapsulation 2003; 20: 375–385
   PubMed Web of Science ®Google Scholar
• Eroglu M, Kusaklioglu H, Misirli Y, Iyisoy A, Acar A, Isin Dogan A, Denkas EB. Chitosan-coated alginate micro spheres for embolization and/or chemoembolization: In vivo studies. Journal of Microencapsulation 2006; 23: 367–376
   PubMed Web of Science ®Google Scholar
• Furuse J, Ishii H, Satake M, Onaya H, Nose H, Mikami S, Sakai H, Mera K, Maru Y, Yoshino M. Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma. American Journal of Clinical Oncology 2003; 26: 159–164
   PubMed Web of Science ®Google Scholar
• Hackman RH. Studies on chitin. I. Enzymic degradation of chitin and chitin esters. Australia Journal of Biological Science 1954; 7: 168–178
   PubMedGoogle Scholar
• Hejazi R, Amiji M. Stomach-specific anti-H. Pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan micro spheres. International Journal of Pharmaceutics 2002; 235: 87–94
   PubMed Web of Science ®Google Scholar
• He P, Davis SS, Illum L. Chitosan microspheres prepared by spray drying. International Journal of Pharmaceutics 1999; 187: 53–65
   PubMed Web of Science ®Google Scholar
• Hirano S, Seino H, Akiyama Y, Nonaka I. Chitosan: A biocompatible material for oral and intravenous administrations. Gebelein CG, Dunn RL, Progress in biomedical polymers. Plenum Press, New York 1990; 283–289
   Google Scholar
• Hsu C, Cheng JC, Cheng AL. Recent advances in non-surgical treatment for advanced hepatocellular carcinoma. Journal of the Formosan Medical Association 2004; 103: 483–495
   PubMed Web of Science ®Google Scholar
• Jameela SR, Jayakrishnan A. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: Studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. Biomaterials 1995; 16: 769–775
   PubMed Web of Science ®Google Scholar
• Jameela SR, Kumary TV, Lal AV, Jayakrishnan A. Progesterone-loaded chitosan microspheres: A long acting biodegradable controlled delivery system. Journal of Controlled Release 1998; 52: 17–24
   PubMed Web of Science ®Google Scholar
• Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. International Journal of Pharmaceutics 2002; 249: 165–174
   PubMed Web of Science ®Google Scholar
• Komemushi A, Tanigawa N, Okuda Y, Kojima H, Fujii H. Shomura Y, Mougawa S, Sawada S. A new liquid embolic material for liver tumors: An animal experimental study using Onyx. Acta Radiologica 2002; 43: 186–191
   PubMed Web of Science ®Google Scholar
• Kumbar SG, Kulkarni AR, Aminabhavi TM. Crosslinked chitosan microspheres for encapsulation of diclofenac sodium effect of crosslinking agent. Journal of Microencapsulation 2002; 19: 173–180
   PubMed Web of Science ®Google Scholar
• Kwak BK, Shim HJ, Han SM, Park ES. Chitin-based embolic materials in the renal artery of rabbits: Pathologic evaluation of an absorbable particulate agent. Radiology 2005; 236: 151–158
   PubMedGoogle Scholar
• Kyotani S, Nishioka Y, Okamura M, Tanaka T, Miyazaki M, Ohnishi S, Yamamoto Y, Ito K, Ogiso T, Tanada S, et al. A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: Antitumor effect of cis-diamminedichloroplatinum (II) albumin microspheres, containing chitin and treated with chitosan on rabbits with VX2 hepatic tumors. Chemical & Pharmaceutical Bulletin (Tokyo) 1992; 40: 2814–2816
   PubMed Web of Science ®Google Scholar
• Liao XF, Yi JL, Li XR, Deng W, Yang ZF, Tian G. Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization. World Journal of Gastroenterology 2004; 10: 1885–1889
   PubMedGoogle Scholar
• Li S, Wang XT, Zhang XB, Yang RJ, Zhang HZ, Zhu LZ, Hou XP. Studies on alginate-chitosan microcapsules and renal arterial embolization in rabbits. Journal of Controlled Release 2002; 84: 87–98
   PubMed Web of Science ®Google Scholar
• Lin WJ, Kang WW. Comparison of chitosan and gelatin coated microparticles: Prepared by hot-melt method. Journal of Microencapsulation 2003; 20: 169–177
   PubMedGoogle Scholar
• Lucinda-Silva RM, Evanglista RC. Microspheres of alginate-chitosan containing isoniazid. Journal of Microencapsulation 2003; 20: 145–152
   PubMed Web of Science ®Google Scholar
• Miya M, Iwamote R, Yoshikawa S, Mima S. I.r. spectroscopic determination of CONH content in highly deacylated chitosan. International Journal of Biological Macromolecule 1980; 2: 323–324
   Web of Science ®Google Scholar
• Muzzarelli R, Baldassarre V, Conti F, Ferrara P, Biagini G, Gazzanelli G, Vasi V. Biological activity of chitosan: Ultrastructural study. Biomaterials 1988; 9: 247–252
   PubMed Web of Science ®Google Scholar
• Nishioka Y, Kyotani S, Okamura M, Miyazaki M, Okazaki K, Ohnishi S, Yamamoto Y, Ito K. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. Chemical & Pharmaceutical Bulletin (Tokyo) 1990; 38: 2871–2873
   PubMed Web of Science ®Google Scholar
• Nishioka Y, Kyotani S, Okamura M, Ohnishi S, Yamamoto Y, Kawashima Y, Tanada S, Nakamura T. A study of embolizing materials for chemoembolization therapy of hepatomacellular carcinoma: Effects of particle size and dose on chitin-containing cis- diaminedichloroplatiuum (α) albumin microsphere antitumor activity in VX2 hepatic tumor model rabbits. Biological Pharmaceutical Bulletin 1994; 17: 1251–1255
   PubMedGoogle Scholar
• Orienti I, Cerchiara T, Luppi B, Bigucci F, Zuccari G, Zccchi V. Influence of differect chitosan salts on the release of sodium diclofenac in colon-specific delivery. International Journal of Pharmaceutics 2002; 238: 51–59
   PubMed Web of Science ®Google Scholar
• Qian J, Truebenbach J, Graepler F, Pereira P, Huppert P, Eul T, Wiemann G, Claussen C. Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9: 94–98
   PubMed Web of Science ®Google Scholar
• Ramsey DE, Geschwind JF. New interventions for liver tumors. Seminars in Roentgenology 2002; 37: 303–311
   PubMedGoogle Scholar
• Sannan T, Kurita K, Ogura K, Iwakura Y. Studies on chitin: 7. I.r. spectroscopic determination of degree of deacetylation. Polymer 1978; 19: 458–459
   Web of Science ®Google Scholar
• Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S. Chitosan microspheres as a potential carrier for drugs. International Journal of Pharmaceutics 2004; 274: 1–33
   PubMed Web of Science ®Google Scholar
• Shu XZ, Zhu KJ, Song W. Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release. International Journal of Pharmaceutics 2001; 212: 19–28
   PubMed Web of Science ®Google Scholar
• Shu XZ, Zhu KJ. The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. European Journal of Pharmaceutics and Biopharmaceutics 2002a; 54: 235–243
   PubMed Web of Science ®Google Scholar
• Shu XZ, Zhu KJ. Controlled drug release properties of ionically cross-linked chitosan beads: The influence of anion structure. International Journal of Pharmaceutics 2002b; 233: 217–225
   PubMed Web of Science ®Google Scholar
• Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S. Chitosan microspheres as a potential carrier for drugs. International Journal of Pharmaceutics 2000; 274: 1–33
   Google Scholar